Evidence map›Paper›PMID 17610535›Full record

ArticleBritish journal of clinical pharmacology2007

Primary care prescribing patterns in Ireland after the publication of large hypertension trials.

Zubair Kabir, John Feely, Kathleen Bennett

Open access · bronzeAbstract read
In one paragraph

Article in British journal of clinical pharmacology, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 2 pooled it
1.4field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 2 syntheses or guidelines pooled it, 17 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Individuals at risk of beta-blocker discontinuation: a cohort study in 19,177 Chinese patients.Clinical research in cardiology : official journal of the German Cardiac Society · 2010
    Article
  6. Article
  7. Article
  8. Choice of first antihypertensive--are existing guidelines ignored?British journal of clinical pharmacology · 2007
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Zubair KabirDepartment of Pharmacology & Therapeutics, Trinity Centre for Health Sciences, St James's Hospital and Trinity College Dublin, Dublin 8, Ireland.
John Feely
Kathleen Bennett
Trinity College Dublin · IESt. James's Hospital · IE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimsThis study assessed prescribing patterns of antihypertensive therapies (AHT) before and after the publication of the LIFE, ALLHAT and VALUE trials between 2000 and 2005.

methodsThe Irish HSE-PCRS prescribing database was used to identify those initiated any AHT. Any change 12 months before and after the trial publications was examined using a segmented regression analysis.

resultsThere was little or no effect of any of the trials on new AHT prescribing, except for ALLHAT where there was an increase in new prescriptions for ACE inhibitors, and VALUE with a slight increase in prescriptions for calcium channel blockers.

conclusionsOur findings show that there was little or no effect of any of the three clinical trials studied on new AHT prescribing patterns in Irish general practice. Future studies should assess any underlying barriers to implementing new evidence into clinical practice.

Indexed as

Antihypertensive AgentsAngiotensin-Converting Enzyme InhibitorsCalcium Channel BlockersClinical Trials as TopicDrug PrescriptionsHumansHypertensionIrelandPractice Patterns, Physicians'Primary Health CareAngiotensin-Converting Enzyme InhibitorsAntihypertensive AgentsCalcium Channel Blockers

Identifiers

PMID17610535
PMCPMC2000662
OpenAlexW2005691625

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.